世界の血管形成術用バルーン市場予測2022年-2027年

【英語タイトル】Angioplasty Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが出版した調査資料(IMARC22OT0044)・商品コード:IMARC22OT0044
・発行会社(調査会社):IMARC
・発行日:2022年8月22日
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥369,852見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥517,852見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥665,852見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

IMARC社では、世界の血管形成術用バルーン市場規模が2021年23億ドルから2027年2.8億ドルに達し、2022年から2027年まで年平均3.4%成長すると予測しています。本調査レポートでは、血管形成術用バルーンの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別(一般バルーン、カッティングバルーン、薬剤溶出性バルーン、スコアリングバルーン)分析、用途別(冠動脈血管形成術、周囲血管形成術)分析、素材別(ナイロン、ポリウレタン、シリコーンウレタン&コポリマー、その他)分析、エンドユーザー別(病院、外来手術センター、その他)分析、地域別(北米、アジア太平洋、ヨーロッパ、中東・アフリカ、中南米)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Abbott Laboratories、B. Braun Melsungen AG、BD (Becton、Dickinson、and Company)、Biotronik SE & Co. KG、Boston Scientific Corporation、Cardinal Health Inc.、Cook Medical LLC、Endocor GmbH & Co. KG、Johnson & Johnson、Medtronic Inc.、Terumo Corporationなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の血管形成術用バルーン市場規模:製品別
- 血管形成術用一般バルーンの市場規模
- 血管形成術用カッティングバルーンの市場規模
- 血管形成術用薬剤溶出性バルーンの市場規模
- 血管形成術用スコアリングバルーンの市場規模
・世界の血管形成術用バルーン市場規模:用途別
- 冠動脈血管形成術用バルーンの市場規模
- 周囲血管形成術用バルーンの市場規模
・世界の血管形成術用バルーン市場規模:素材別
- ナイロン製血管形成術用バルーンの市場規模
- ポリウレタン製血管形成術用バルーンの市場規模
- シリコーンウレタン&コポリマー製血管形成術用バルーンの市場規模
- その他素材製の血管形成術用バルーン市場規模
・世界の血管形成術用バルーン市場規模:エンドユーザー別
- 病院における血管形成術用バルーンの市場規模
- 外来手術センターにおける血管形成術用バルーンの市場規模
- その他エンドユーザーにおける血管形成術用バルーンの市場規模
・世界の血管形成術用バルーン市場規模:地域別
- 北米の血管形成術用バルーン市場規模
- アジア太平洋の血管形成術用バルーン市場規模
- ヨーロッパの血管形成術用バルーン市場規模
- 中南米の血管形成術用バルーン市場規模
- 中東・アフリカの血管形成術用バルーン市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

The global angioplasty balloons market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Angioplasty balloons refer to the medical devices that are used for unblocking and widening clogged blood vessels during surgical procedures. Some of the common types of angioplasty balloons include drug-eluting, normal, scoring and cutting balloons. They are usually manufactured using nylon, polyurethane and silicone urethane polymers and consist of nitinol constraining structures that create grooves and pillows on the surface of the balloon to offer predictable, uniform and atraumatic dilation. During the surgery, the balloon is inflated to flatten the plaque against the wall of the blood vessels, thereby opening them and restoring the normal blood flow.

The increasing prevalence of coronary and periphery artery diseases across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population and individuals suffering from obesity and high levels of cholesterol are also providing a boost to the market growth. Furthermore, there is an increasing preference for drug-coated angioplasty balloons that offer superior safety, effectiveness and improved blood flow throughout the body. This has also reduced the utilization of vessel implants, such as stents, which may cause vessel fracture. Additionally, various technological advancements, such as the development of imaging technologies, and the advent of innovative variants that can be implanted without administering general anesthesia, are also acting as major growth-inducing factors. Increasing health consciousness among consumers, improving healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences are some of the other factors that are projected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global angioplasty balloons market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application, material and end-user.

Breakup by Product Type:

Normal Balloons
Cutting Balloons
Drug Eluting Balloons
Scoring Balloons

Breakup by Application:

Coronary Angioplasty
Peripheral Angioplasty

Breakup by Material:

Nylon
Polyurethane
Silicone Urethane Co-Polymers
Others

Breakup by End-User:

Hospitals
Ambulatory Surgery Centers
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun Melsungen AG, BD (Becton, Dickinson, and Company), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Endocor GmbH & Co. KG, Johnson & Johnson, Medtronic Inc., Terumo Corporation, etc.

Key Questions Answered in This Report:

How has the global angioplasty balloons market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global angioplasty balloons market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the material?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global angioplasty balloons market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Angioplasty Balloons Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Normal Balloons
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cutting Balloons
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Drug Eluting Balloons
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Scoring Balloons
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Coronary Angioplasty
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Peripheral Angioplasty
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Material
8.1 Nylon
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Polyurethane
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Silicone Urethane Co-Polymers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End-User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgery Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 B. Braun Melsungen AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BD (Becton, Dickinson and Company)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biotronik SE & Co. KG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Boston Scientific Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Cardinal Health Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Cook Medical LLC
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8 Endocor GmbH & Co. KG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Johnson & Johnson
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Medtronic Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Terumo Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis



★調査レポート[世界の血管形成術用バルーン市場予測2022年-2027年] (コード:IMARC22OT0044)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血管形成術用バルーン市場予測2022年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆